Nicholas Paul Nunnally, D.O. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1375 N Main St, Lapeer, MI 48446 Phone: 810-667-5590 |
Robert Moore Stenz, D.O. Surgery Medicare: Accepting Medicare Assignments Practice Location: 3273 Davison Rd, Suite #4, Lapeer, MI 48446 Phone: 810-667-5150 Fax: 810-667-6334 |
Dr. William V Zemnickas Ii, D.O Surgery Medicare: Accepting Medicare Assignments Practice Location: 844 S Main St, Lapeer, MI 48446 Phone: 810-664-4100 Fax: 810-664-9250 |
Dr. Ratan Rajani, MD Surgery Medicare: Medicare Enrolled Practice Location: 844 S Main St, Lapeer, MI 48446 Phone: 810-664-4100 Fax: 810-664-9250 |
Dr. Forrest D Robart, D.O. Surgery Medicare: Accepting Medicare Assignments Practice Location: 844 S Main St, Lapeer, MI 48446 Phone: 810-664-4100 Fax: 810-664-9250 |
News Archive
The earlier that patients who suffer from atrial fibrillation obtain the correct treatment, the lower is the risk of serious secondary effects such as stroke. A thesis presented at the University of Gothenburg, Sweden, shows that a well-established measurement score can easily assess the risks for this patient group.
Targanta Therapeutics Corporation has released the in vivo data from a preclinical study comparing the activity of its antibiotic drug candidate, oritavancin, to vancomycin in a hamster model of Clostridium difficile infection.
Avvo (www.avvo.com), the world's largest online directory for doctors and lawyers that provides free rankings for 90% of the working physicians in the U.S., continues to grow the number of service features offered on its medical website - to bring doctors and patients the latest, breakthrough online directory tools. This month, Avvo unveils a new Hospital Sort capability that further enables users to hone in on the comprehensive information they need to make their physician search even more effective, and that also helps doctors and hospitals to more easily reach prospective patients.
Mayo Clinic Cancer Center investigators report that combination therapy with lenalidomide (Revlimid) and dexamethasone (combination is called Rev/Dex) looks like a breakthrough treatment for multiple myeloma. Results of a Phase II clinical trial were published online Aug. 23 in Blood.
› Verified 6 days ago